Odyssey Therapeutics, Inc.
ODTX
$19.18
$0.291.51%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -38.26M | -38.44M | |||
| Total Depreciation and Amortization | 1.17M | 1.30M | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 3.25M | 3.80M | |||
| Change in Net Operating Assets | -7.19M | -5.28M | |||
| Cash from Operations | -41.04M | -38.62M | |||
| Capital Expenditure | -148.00K | -927.00K | |||
| Sale of Property, Plant, and Equipment | -- | 54.00K | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 34.95M | 35.00M | |||
| Cash from Investing | 34.80M | 34.13M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -24.00K | -35.00K | |||
| Issuance of Common Stock | 651.00K | 235.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -143.00K | -- | |||
| Cash from Financing | 484.00K | 200.00K | |||
| Foreign Exchange rate Adjustments | 24.00K | 69.00K | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -5.73M | -4.23M | |||